Cargando…
Novel coronavirus pandemic: A clinical overview
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emergent public health crisis threatening the current world health establishment. The SARS-Co-2 was first identified in Wuhan, Hubei Province, China, in December 2019. There have been about 6.5 million reported cases...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377866/ https://www.ncbi.nlm.nih.gov/pubmed/32633997 http://dx.doi.org/10.4102/safp.v62i1.5123 |
_version_ | 1783740726478110720 |
---|---|
author | Kaswa, Ramprakash Govender, Indiran |
author_facet | Kaswa, Ramprakash Govender, Indiran |
author_sort | Kaswa, Ramprakash |
collection | PubMed |
description | The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emergent public health crisis threatening the current world health establishment. The SARS-Co-2 was first identified in Wuhan, Hubei Province, China, in December 2019. There have been about 6.5 million reported cases of coronavirus disease 2019 (COVID-19) and about 350 000 reported deaths throughout the world within the last 6 months from the onset of the epidemic. The virus is primarily transmitted by inhalation or contact with infected droplets. The COVID-19 patient usually presents with fever, cough, sore throat and breathlessness. Currently, available data indicate that the majority of people with the disease have mild symptoms, while about 20% present with moderate-to-severe disease. About 5% of these may progress to pneumonia, acute respiratory distress syndrome and multi-organ dysfunction. To date, there is no recommended medical treatment, and supportive measures are a crucial part of management. The case fatality rate of SARS-CoV-2 is lower than that of its two coronavirus predecessors, that is, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). The full impact of this new pandemic on health, social and economic well-being of humankind is yet to be ascertained. |
format | Online Article Text |
id | pubmed-8377866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AOSIS |
record_format | MEDLINE/PubMed |
spelling | pubmed-83778662021-09-03 Novel coronavirus pandemic: A clinical overview Kaswa, Ramprakash Govender, Indiran S Afr Fam Pract (2004) CPD Article The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emergent public health crisis threatening the current world health establishment. The SARS-Co-2 was first identified in Wuhan, Hubei Province, China, in December 2019. There have been about 6.5 million reported cases of coronavirus disease 2019 (COVID-19) and about 350 000 reported deaths throughout the world within the last 6 months from the onset of the epidemic. The virus is primarily transmitted by inhalation or contact with infected droplets. The COVID-19 patient usually presents with fever, cough, sore throat and breathlessness. Currently, available data indicate that the majority of people with the disease have mild symptoms, while about 20% present with moderate-to-severe disease. About 5% of these may progress to pneumonia, acute respiratory distress syndrome and multi-organ dysfunction. To date, there is no recommended medical treatment, and supportive measures are a crucial part of management. The case fatality rate of SARS-CoV-2 is lower than that of its two coronavirus predecessors, that is, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). The full impact of this new pandemic on health, social and economic well-being of humankind is yet to be ascertained. AOSIS 2020-06-26 /pmc/articles/PMC8377866/ /pubmed/32633997 http://dx.doi.org/10.4102/safp.v62i1.5123 Text en © 2020. The Authors https://creativecommons.org/licenses/by/4.0/Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License. |
spellingShingle | CPD Article Kaswa, Ramprakash Govender, Indiran Novel coronavirus pandemic: A clinical overview |
title | Novel coronavirus pandemic: A clinical overview |
title_full | Novel coronavirus pandemic: A clinical overview |
title_fullStr | Novel coronavirus pandemic: A clinical overview |
title_full_unstemmed | Novel coronavirus pandemic: A clinical overview |
title_short | Novel coronavirus pandemic: A clinical overview |
title_sort | novel coronavirus pandemic: a clinical overview |
topic | CPD Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377866/ https://www.ncbi.nlm.nih.gov/pubmed/32633997 http://dx.doi.org/10.4102/safp.v62i1.5123 |
work_keys_str_mv | AT kaswaramprakash novelcoronaviruspandemicaclinicaloverview AT govenderindiran novelcoronaviruspandemicaclinicaloverview |